CMS Releases Guidance on Meningitis Outbreak Coverage

CMS has issued guidance on Medicare coverage for those affected by the meningitis outbreak.


Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

CMS believes that, aside from oral drugs, items and services to diagnose and treat patients who have received contaminated steroid products produced by the New England Compounding Center qualify for the Medicare Part A or Part B benefit.

CMS has also urged Medicare contractors to review CDC updates to ensure timely access to recommended healthcare items and services and to expedite all coverage determination requests for those items and services to include antifungal medication.

More Articles on Patient Safety:

6 Tips for Proper Housekeeping in an Ambulatory Surgery Center

3 Best Practices for Public Reporting of Quality Information

Joint Commission Releases ASC, Office-Based Surgery 2013 Patient Safety Goals

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Patient Safety Tools & Resources Database

Top 40 Articles from the Past 6 Months